BILL ANALYSIS

HR8297

BULLISH

District of Columbia Firearm Freedom Act

HR8297 (District of Columbia Firearm Freedom Act) has been assessed with a bullish outlook for investors. The primary sectors impacted are Manufacturing and Consumer. View the full bill text on Congress.gov.

bullish

Market Sentiment

4/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR8297 is an early-stage bill with no hearings, no markup, and no appropriations — it is not a market catalyst.

The bill would deregulate D.C.'s firearms market by removing feature-based bans and registration requirements, benefiting pure-play manufacturers SWBI and RGR but at a de minimis revenue level.

Real market data shows SWBI and RGR trading near 52-week highs with 7-9% gains over the past 30 days, but this bill alone does not explain those moves.

How HR8297 Affects the Market

The market impact of HR8297 at this stage is effectively zero. SWBI at $15.58 and RGR at $43.60 are trading near their 52-week highs, with both stocks posting 7-9% gains over the past 30 days. However, those moves are better attributed to broader sector trends and Supreme Court signals than to this single procedural bill. Investors should treat this as a non-event until the bill advances past committee — which is highly unlikely in the current Congress.

Bill Details

Metric	Value
Bill Number	HR8297
Market Sentiment	bullish
Event Date	April 15, 2026
Affected Sectors	Manufacturing, Consumer
Source	View on Congress.gov →

Summary

HR8297 is a bill introduced April 15, 2026, that would remove D.C.'s feature-based firearm bans, registration requirements, and concealed carry restrictions. It is in the earliest procedural stage — referred to two committees — with zero appropriations. The bill is not a market-moving catalyst at this stage. Pure-play firearm manufacturers SWBI and RGR would benefit structurally if enacted, but D.C. represents a negligible share of the U.S. firearms market.

Full AI Market Analysis

1) WHAT HAPPENED: On April 15, 2026, Representative Dan Crenshaw (R-TX) introduced H.R. 8297, the District of Columbia Firearm Freedom Act. It was referred to the Committee on Oversight and Government Reform and the Committee on the Judiciary. The bill has had zero further actions since referral — it is purely procedural with no hearings, markups, or votes scheduled. It is an early-stage authorization bill with no spending attached. 2) THE MONEY TRAIL: This bill contains no appropriations — it is a deregulation measure, not a government spending bill. There is no funding amount to track. The economic impact comes from expanding the legal market for firearms in D.C. by removing feature-based bans (e.g., bans on semiautomatic rifles with certain features like detachable magazines and pistol grips), eliminating registration requirements, and allowing concealed carry without a may-issue license. D.C.'s population is approximately 700,000, or 0.21% of the U.S. population. Even assuming a generous incremental firearm purchase rate of 5-10 new units per 100 residents, the addressable unit volume is 35,000-70,000 units per year, representing roughly $20-50 million in retail revenue spread across all manufacturers and dealers. For context, SWBI's FY2025 revenue was approximately $450 million and RGR's was $550 million. 3) STRUCTURAL WINNERS AND LOSERS: Pure-play firearm manufacturers SWBI (Smith & Wesson) and RGR (Sturm, Ruger) are structurally positioned to capture incremental sales if D.C. repeals its feature bans. Both manufacture the product categories currently restricted (AR-15 style rifles and modern sporting handguns). However, the revenue uplift is de minimis — likely less than 2% of annual revenue even at full enactment. No tickers are negatively affected by this bill; it is purely permissive. 4) REAL MARKET DATA: SWBI closed at $15.58 on April 30, 2026, near its 52-week high of $15.74. The stock has risen 3.87% in the last 7 days and 8.72% in the last 30 days. RGR closed at $43.60, up 2.66% in 7 days and 8.76% in 30 days. The price action for both stocks has been positive over the past month, but this bill's introduction on April 15 is only one potential contributing factor. Broader sector trends, including potential Supreme Court Second Amendment cases and state-level deregulation, are likely more significant drivers. 5) TIMELINE: The bill faces a long and uncertain path. It must pass through two House committees (Oversight and Government Reform, and Judiciary), then secure a floor vote in the House. Even if it passes the House, it would need 60 votes in the Senate to overcome a filibuster. With the current Senate composition (119th Congress), this is extremely unlikely. No hearings have been scheduled. The bill is effectively parked in committee.